GILBERT ENDRIGA: Open Payments
NPI 1790465243 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 38 payments from 13 companies in 2025. Trend: 2023 $196 · 2024 $398 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $223 |
| Novo Nordisk Inc | 6 | $184 |
| Amgen Inc. | 4 | $183 |
| Insulet Corporation | 3 | $174 |
| Sequel Med Tech, LLC | 1 | $172 |
| Madrigal Pharmaceuticals | 7 | $137 |
| Rhythm Pharmaceuticals, Inc. | 2 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $47 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $43 |
Products named: MINIMED 780G, Ozempic, Omnipod, TWIIST, EVENITY, REZDIFFRA, IMCIVREE, MOUNJARO.
Industry payments across NY — which companies pay providers there.
